Bloomberg ranked the 500 richest people in the world in its Bloomberg Billionaires Index, with several healthcare names making the list.

 

A new virus that presents with SARS-like symptoms has been discovered in China and already spread to at least two people in the United States, according to the CDC.

Hospitals have partnered with several technology giants, including Microsoft, IBM, Google and Amazon and handed over valuable and identifiable patient information in data deals, according to The Wall Street Journal.

CMS is planning to launch a simplified comparison tool for Medicare beneficiaries to find care.

The pharmaceutical industry upped its lobbying efforts in 2019, with a record-high of $29 million spent lobbying Congress.

Medicare beneficiaries can receive acupuncture to treat lower back pain after CMS finalized coverage on Jan. 21. The treatment was previously non-covered by Medicare and was reviewed by CMS with evidence and examinations of policies of private payers.

Civica Rx and the Blue Cross Blue Shield Association and 18 of its health plans have teamed up to create a new subsidiary that will target low-cost generic drugs.

One-third of healthcare administrative spending could be automated and save $13.3 billion, according to a report by CAQH.

Centene has passed all regulatory hurdles to seal the deal on a merger with WellCare Health Plans worth $17.3 billion.

Amazon is signaling it may soon sell prescription drugs in the U.K., Canada and Australia after the company moved to trademark “Amazon Pharmacy” in those countries at the start of 2020, CNBC reported.

More accountable care organizations are taking on downside financial risk in the Medicare Shared Savings Program than ever before, with 37% in the program today participating in these arrangements.

The Supreme Court won’t take up the ongoing appeal over the constitutionality of the Affordable Care Act, leaving the decision in the hands of a lower court.